Mabwell (Shanghai) Bioscience Co., Ltd. Share Price
Equities
688062
CNE100005RD2
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.6 CNY | +1.33% | -3.50% | +2.78% |
05-07 | Mabwell Announces FDA Grants Orphan Drug Designation to 9MW2821 | CI |
04-29 | Mabwell Bioscience Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 341M 47.18M 3.71B | Sales 2025 * | 1.09B 150M 11.84B | Capitalization | 13.43B 1.86B 146B |
---|---|---|---|---|---|
Net income 2024 * | -894M -124M -9.74B | Net income 2025 * | -622M -86.12M -6.78B | EV / Sales 2024 * | 39.4 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 12.4 x |
P/E ratio 2024 * |
-15
x | P/E ratio 2025 * |
-21.6
x | Employees | 1,491 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.33% |
1 day | +1.33% | ||
1 week | -3.50% | ||
Current month | -5.00% | ||
1 month | +7.69% | ||
3 months | +26.70% | ||
6 months | +26.79% | ||
Current year | +2.78% |
Managers | Title | Age | Since |
---|---|---|---|
Da Tao Liu
CEO | Chief Executive Officer | 52 | 30/06/17 |
Jin Hua
DFI | Director of Finance/CFO | 43 | 26/06/23 |
Xin Du
CTO | Chief Tech/Sci/R&D Officer | 52 | 31/05/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bo Ling Li
BRD | Director/Board Member | 70 | 10/10/20 |
Chun Shan Tang
BRD | Director/Board Member | 55 | 31/03/19 |
Da Tao Liu
CEO | Chief Executive Officer | 52 | 30/06/17 |
Date | Price | Change | Volume |
---|---|---|---|
16/05/24 | 33.6 | +1.33% | 982 850 |
16/05/24 | 33.16 | -1.37% | 972,277 |
15/05/24 | 33.62 | -2.21% | 1,412,712 |
14/05/24 | 34.38 | +0.23% | 1,212,769 |
13/05/24 | 34.3 | -1.97% | 1,899,948 |
End-of-day quote Shanghai S.E., May 16, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.78% | 1.84B | |
+9.43% | 114B | |
+11.38% | 104B | |
-13.75% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.98% | 17.89B | |
+7.65% | 14.28B | |
+34.59% | 12.55B |
- Stock Market
- Equities
- 688062 Stock